2017年2月14日に大阪で行われました、NPO法人新共創産業技術支援機構（ITAC）主催の「イスラエル ビジネス技術交流会」にて、弊社代表のイラ・プリガットがイスラエルの最新テクノロジーに関する講演を行わせていただきました。

【講演タイトル】
The EndoPAT Technology – A Revolutionary Bio-Marker for Early Detection of Disease

すでに日本でも多くの大学や病院で使用されている血管内皮機能検査機器をはじめ、バクテリアコミュニケーションのお話など、たくさんの反響をいただきました。

At the “Israel Business Technology Exchange” held on February 14, 2017 in Osaka, sponsored by the New Co-Creative Industry Technology Support Organization (ITAC), Ira Prigat gave a lecture about the latest technological innovation in Cardiology. 

In a lecture called “The EndoPAT Technology – A Revolutionary Bio-Marker for Early Detection of Disease”, Ira discussed the importance of Endothelial Dysfunction risk assessment developed by and Israeli company called Itamar Medical, which was inspired by a 1980 Nobel Prize revolution. That group of researchers revealed importance of Endothelial Dysfunction assessment as the earliest sign for cardiovascular events. 

The second scientific revolution Ira discussed was the  “Quorum sensing & Bacterial communication in the aid of disease prevention”. A revolutionary with chemical and biological roots, which present the ability to prevent disease by disturbing bacteria communication, thus to prevent them from attacking the body.

We have received a lot of feedback, including talks on bacterial communication, including vascular endothelial function testing equipment already used in many universities and hospitals in Japan.